在COVID-19后的肺部恢复 - 一个审查
Thomas Sonnweber1, Sailer Birgit1, Günter Weiss1,2
1Department of Internal Medicine II, Medical University Innsbruck, Innsbruck, Austria.
Expert review of respiratory medicine
|July 14, 2023
概括
严重的COVID-19可能会对幸存者造成持久的肺损伤. 许多住院患者显示持续肺部异常超过一年,强调需要进一步研究长期COVID-19后果.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 放射学 放射学是一门学科.
背景情况:
- 由SARS-CoV-2引起的COVID-19主要影响呼吸系统.
- 严重的病例往往需要氧气或通风由于肺病理.
- 在严重COVID-19的幸存者中经常观察到肺部异常.
研究的目的:
- 审查当前关于成年COVID-19肺炎幸存者的肺部恢复的证据.
- 突出COVID-19后持续性肺部异常的患病率和影响.
主要方法:
- 关于COVID-19后肺部恢复研究的文献综述.
- 专注于COVID-19肺炎的成年患者.
- 对随访数据的分析,包括计算机断层扫描的发现.
主要成果:
- 严重的COVID-19与持续性肺部异常的高发病率有关.
- 计算机断层扫描随访显示,许多幸存者的结构性肺部问题.
- 大约三分之一的住院患者至少在发病12个月后出现异常.
结论:
- 在严重的COVID-19幸存者中,持续的肺部异常很常见.
- 这些发现的长期临床意义需要进一步调查.
- 识别面临长期COVID-19后果风险的个人至关重要.
相关概念视频
COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:


